NO20044709L - Kombinasjonsterapi mot tumorer omfattende substituerte akryloyldistamycinderivater og rontgenbehandling - Google Patents

Kombinasjonsterapi mot tumorer omfattende substituerte akryloyldistamycinderivater og rontgenbehandling

Info

Publication number
NO20044709L
NO20044709L NO20044709A NO20044709A NO20044709L NO 20044709 L NO20044709 L NO 20044709L NO 20044709 A NO20044709 A NO 20044709A NO 20044709 A NO20044709 A NO 20044709A NO 20044709 L NO20044709 L NO 20044709L
Authority
NO
Norway
Prior art keywords
distamycin derivatives
against tumors
acryloyl distamycin
therapy
substituted acryloyl
Prior art date
Application number
NO20044709A
Other languages
English (en)
Inventor
Camilla Fowst
Maria Cristina Rosa Geroni
Jennifer Margaret Tursi
Original Assignee
Pharmacia Italia Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pharmacia Italia Spa filed Critical Pharmacia Italia Spa
Publication of NO20044709L publication Critical patent/NO20044709L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K41/00—Medicinal preparations obtained by treating materials with wave energy or particle radiation ; Therapies using these preparations
    • A61K41/0038—Radiosensitizing, i.e. administration of pharmaceutical agents that enhance the effect of radiotherapy
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/4025—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil not condensed and containing further heterocyclic rings, e.g. cromakalim
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A61K33/243—Platinum; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K41/00—Medicinal preparations obtained by treating materials with wave energy or particle radiation ; Therapies using these preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Inorganic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pyrrole Compounds (AREA)

Abstract

Foreliggende oppfinnelse tilveiebringer anvendelse av akryloyldistamycinderivater, spesielt a-brom- eller a-klor-akryloyldistamycinderivater, i kombinasjon med radioterapi ved behandling av tumorer.
NO20044709A 2002-04-02 2004-11-01 Kombinasjonsterapi mot tumorer omfattende substituerte akryloyldistamycinderivater og rontgenbehandling NO20044709L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP02076240 2002-04-02
PCT/EP2003/003192 WO2003082267A1 (en) 2002-04-02 2003-03-17 Combined therapy against tumors comprising substituted acryloyl distamycin derivatives and radiotherapy

Publications (1)

Publication Number Publication Date
NO20044709L true NO20044709L (no) 2004-12-30

Family

ID=28459529

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20044709A NO20044709L (no) 2002-04-02 2004-11-01 Kombinasjonsterapi mot tumorer omfattende substituerte akryloyldistamycinderivater og rontgenbehandling

Country Status (20)

Country Link
US (1) US20110166077A9 (no)
EP (1) EP1490053B1 (no)
JP (1) JP2005527552A (no)
KR (1) KR100968657B1 (no)
CN (1) CN1302777C (no)
AT (1) ATE383154T1 (no)
AU (1) AU2003219102B2 (no)
BR (1) BR0308976A (no)
CA (1) CA2481005C (no)
DE (1) DE60318561T2 (no)
ES (1) ES2299692T3 (no)
HK (1) HK1079116A1 (no)
IL (2) IL164356A0 (no)
MX (1) MXPA04009542A (no)
NO (1) NO20044709L (no)
NZ (1) NZ535700A (no)
PL (1) PL373998A1 (no)
RU (1) RU2314807C2 (no)
WO (1) WO2003082267A1 (no)
ZA (1) ZA200407948B (no)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0015446D0 (en) * 2000-06-23 2000-08-16 Pharmacia & Upjohn Spa Combined therapy against tumors comprising substituted acryloyl distamycin derivates,taxanes and/or antimetabolites
BRPI0408494A (pt) * 2003-03-18 2006-04-04 Pharmacia Italia Spa terapia combinada contra tumores compreendendo nemorubicina com terapia de radiação
ES2335805T3 (es) * 2005-04-08 2010-04-05 Nerviano Medical Sciences S.R.L. Combinacion antitumoral que comprende derivados de acriloil distamicina sustituidos y anticuerpos inhibidores de factores de crecimiento o de sus receptores.
RU2478374C1 (ru) * 2012-02-06 2013-04-10 Федеральное государственное бюджетное учреждение "Ростовский научно-исследовательский онкологический институт" Минздравсоцразвития России Способ внутриполостной терапии при лечении больных с метастазами рака во влагалище

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1990012321A1 (en) * 1989-03-31 1990-10-18 The Cancer Institute Board Halogenated dna ligand radiosensitisers for cancer therapy
JPH0925268A (ja) * 1995-07-12 1997-01-28 Taiho Yakuhin Kogyo Kk ２−ニトロイミダゾール誘導体
GB9615692D0 (en) * 1996-07-25 1996-09-04 Pharmacia Spa Acryloyl substituted distamycin derivatives, process for preparing them, and their use as antitumor and antiviral agents
US6331286B1 (en) * 1998-12-21 2001-12-18 Photogen, Inc. Methods for high energy phototherapeutics
CA2332331A1 (en) * 1998-05-15 1999-11-25 Francisco Robert Treatment of human tumors with radiation and inhibitors of growth factor receptor tyrosine kinases
US6498181B1 (en) * 1999-01-06 2002-12-24 Maxim Pharmaceuticals Synergistic tumorcidal response induced by histamine
US6576759B2 (en) * 1999-02-10 2003-06-10 Pangene Corporation Antisense inhibition of RAD51
GB0011059D0 (en) * 2000-05-08 2000-06-28 Pharmacia & Upjohn Spa Use of substituted acryloyl distamycin derivatives in the treatment of tumours associated with high levels of glutathione
GB0015447D0 (en) * 2000-06-23 2000-08-16 Pharmacia & Upjohn Spa Combined therapy against tumors comprising substituted acryloyl derivates and alkylating agents
US6576612B1 (en) * 2000-10-02 2003-06-10 Pharmacia Italia S.P.A. Antitumor therapy comprising distamycin derivatives

Also Published As

Publication number Publication date
CA2481005A1 (en) 2003-10-09
PL373998A1 (en) 2005-09-19
MXPA04009542A (es) 2005-01-25
JP2005527552A (ja) 2005-09-15
HK1079116A1 (en) 2006-03-31
WO2003082267A1 (en) 2003-10-09
AU2003219102B2 (en) 2008-05-08
AU2003219102A1 (en) 2003-10-13
IL164356A0 (en) 2005-12-18
DE60318561D1 (de) 2008-02-21
CA2481005C (en) 2009-06-09
NZ535700A (en) 2007-06-29
CN1649583A (zh) 2005-08-03
IL164356A (en) 2010-11-30
CN1302777C (zh) 2007-03-07
US20050143315A1 (en) 2005-06-30
RU2314807C2 (ru) 2008-01-20
DE60318561T2 (de) 2009-01-08
KR100968657B1 (ko) 2010-07-06
EP1490053A1 (en) 2004-12-29
ES2299692T3 (es) 2008-06-01
US20110166077A9 (en) 2011-07-07
KR20040101379A (ko) 2004-12-02
BR0308976A (pt) 2005-01-11
ATE383154T1 (de) 2008-01-15
ZA200407948B (en) 2006-08-30
EP1490053B1 (en) 2008-01-09
RU2004131860A (ru) 2005-04-10

Similar Documents

Publication Publication Date Title
TW200501960A (en) Synergistic kits and compositions for treating cancer
CY1106766T1 (el) Παραγωγα πυριδινης ως αναστολεις raf κινασης
DK1372650T3 (da) Kombinationer indeholdende et antidiarrémiddel og en epothilon eller et epothilonderivat
NO20050427L (no) Carvedilolfosfatsalter og/eller solvater derav, tilsvarende preparater og/eller behandlingsfremgangsmater
IT1333697B (no)
DK1853250T3 (da) Kombinationer og måder til indgivelse af terapeutiske midler og kombinationsterapi
MY138059A (en) Use of ikb-kinase inhibitors in pain therapy
NO20054988D0 (no) Preparater og metoder for behandling av cancer
NO20053817D0 (no) Preparater og fremgangsmater for antiviral kombinasjonsterapi.
TR200102499T2 (tr) Neoplazi tedavisinde bir kombinasyon terapisi olarak bir siklooksijenaz-2 inhibitörü ve bir veya daha fazla antineoplastik ajan kullanma yöntemi
ATE461217T1 (de) Glp-1-verbindungen
PL1682126T3 (pl) Podstawione benzazole i ich zastosowanie jako inhibitorów kinazy Raf
SG145700A1 (en) Pyridyl derivatives and their use as therapeutic agents
WO2004113571A3 (en) Prostate specific genes and the use thereof as targets for prostate cancer therapy and diagnosis
IL164599A0 (en) Combination therapy for the treatment of cancer
HK1050860A1 (en) Nordihydroguaiaretic derivatives for use in treatment of tumors
ATE411981T1 (de) Tetrahydrocarbazolderivate und deren pharmazeutische verwendung
SE0301650D0 (sv) Novel compounds
HK1079116A1 (en) Combined therapy against tumors comprising substituted acryloyl distamycin derivatives and radiotherapy
IS5570A (is) Meðhöndlun á risaeitlingasarkmeini með tálmum viðeitilfrumueiturslóðinni
HK1074840A1 (en) Novel dithiolopyrrolones with therapeutic activity
HK1084954A1 (en) Ruthenium(II) complexes for the treatment of tumors
AU2003229876A1 (en) Tumour associated antigens
MXPA05002477A (es) Asialo-interferones y el tratamiento de cancer de higado.
AU2003288263A1 (en) Use of substituted acrylolyl distamycin derivatives in combination with demethylating agents, in the treatment of cancer

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application